The Hellenic Cancer Federation (ELLOK) is organizing its 9th Annual Conference on February 3rd, 4th, and 5th, 2025,' which will take place at the Wyndham Grand Athens Hotel.
The annual conference of ELLOK, as every year, is anchored around World Cancer Day on February 4th aiming to highlight important health policy issues and developments that affect the quality of oncology care and treatment provided.
The 9th Conference of the Hellenic Cancer Federation is part of the three-year (2025-2027) Campaign of the Union for International Cancer Control (U.I.C.C), titled "United by Unique".
Main Topics
In an era that could prove to be a turning point for the future of oncology, due to the Greek state's clear determination to address cancer as a major health issue in alignment with European institutions, the significant technological advancements that are opening new horizons in the treatment of the disease, and the ongoing consultation among all oncology stakeholders, the 9th' conference aims to highlight and provide updates on major issues related to oncology care in Greece and Europe.
The sessions will include presentations, roundtable discussions, and studies and research presentations from Greece and Europe, featuring distinguished speakers, scientists, politicians, and patient representatives. More specifically:. .
- The framework for the implementation of the announced National Cancer Plan and the corresponding creation of the National Cancer Registry.
- The connection and collaboration between the legislative bodies of our country and their European counterparts to prioritize cancer as a major health issue.
- The quality and safety of healthcare services in Greece and Europe.
- The new national screening programs as a pivotal strategic choice for the country in addressing cancer.
- The implementation plan of the National Node "Mission for Cancer"
- The importance of Primary Healthcare as the starting point of health systems.
- Ways to address the multifaceted inequalities in oncology care and the discontinuity of cancer care in pediatric oncology.
- The role of patients' participation in decision making
- The implementation of digital transformation and its benefits for patients and healthcare providers.
- The need to adopt a new model for healthcare economics management.
- Clinical trials that can and should serve as the main vehicle for entering the new era of cancer treatment.
- The multidimensional benefits of creating a Health Technology Assessment (HTA) organization.
- The adoption of a new framework for the approval and reimbursement of biomarkers.
- The latest innovative developments in medical devices and their role in oncology care.
- The presentation of the All.Can International study "Action Guide For Efficient Cancer Care" for evaluating the effectiveness of the services provided throughout the patient's journey.
- The presentation of the report by the Organisation for Economic Co-operation and Development (OECD) for Greece.
- The presentation of the results of the report on the experience of cancer patients with their interactions with the Greek healthcare system.
Our goal is the active participation and interaction of the attendees and the audience in order to highlight the most important issues in cancer treatment, as well as to present relevant proposals and solutions from political entities, the academic and scientific fields, healthcare professionals, the industry, and patient organizations.
The Conference, which after eight years of successful execution has now established itself as the leading annual event of ELLOK and a milestone for the oncology community in our country, aims to be a reference point for fostering dialogue among all stakeholders in cancer care, contributing to its improvement and strengthening the role of patients in decisions concerning their treatment and quality of life.
Session 1:
|
|
| 08:50 – 09:00 | Opening – Welcome address |
| 09:00 – 09:30 | Messages João Breda Dimitrios Tsiodras Elena Kountoura Nikos Papandreou |
| 09:30 – 09:45 | Keynote speech: The National Screening Programs as the central strategy for public health Eirini Agapidaki |
| 09:45 – 10:45 | Developing a Healthcare system that ensures quality healthcare services Moderator:Maria Samolada João Breda Meletios-Athanasios Dimopoulos Theodoros Agorastos Ioannis Yfantopoulos Amanda Psirri Eleftherios Thireos Despoina Topali |
| 10:45 – 11:15 | Break |
| 11:15 – 12:15 | Bridging the transition gap in pediatric cancer Moderator: Theodora Psaltopoulou Olga Balaoura Gevorg Tamamyan Aristotelis Bamias Antonis Kattamis Menia Koukougianni |
| 12:15 – 13:15 | Shared Decision Making and Patient Empowerment Moderator: Athanasia Printza Nikolaos Vassos Michalis Nikolaou Aikaterini Papadopoulou - Machaira Nikolaos Dedes Angeliki Stefanaki |
| 13:15 – 14:15 | Lunch |
Session 2:
|
|
| 14:15 – 15:15 | Presentation of the All.Can Action Guide – A Guide for the improvement of cancer care efficiency Moderator: Athanasios Vozikis Eduardo Pisani Olga Balaoura Anastasios Karandreas Sarandos Eustathopoulos Maria Tolia Dimitrios Papageorgiou |
| 15:15 – 16:00 | The challenges in developing an HTA Organization Moderator: Kostas Athanasakis Aris Angelis Flora Bacopoulou Chara Kani Dimitrios Athanasiou Anastasios Boutis Paraskevi Mixalopoulou |
| 16:00 – 16:15 | Break |
| 16:15 – 17:00 | A New Framework for Biomarkers: From planning to implementation Moderator: Kostas Athanasakis Aris Angelis Theano Karpodini Zenia Saridaki - Zorras Eleni Kourea Christos Georgakopoulos Christos Antonopoulos Nikolaos Tsoulos George Kapetanakis |
| 17:00 – 17:45 | Supporting Centers of Excellence – Promoting efficiency Moderator: Aimilios Negkis Grigorios Kaltsas Sofia Chatziioannou Sofia Koukouraki Charalambos Karathanos Spiros Apostolopoulos |
| 17:45 – 18:00 | Break |
| 18:00 – 18:45 | How can Tumor Boards Support Quality Care Moderator: Aristotelis Bamias Nikos Arkadopoulos Maria Tolia Dimitrios Papageorgiou Eleutherios Eleutheriadis Paraskevi Mixalopoulou |
| 18:45 – 19:45 | Cancer & Comorbidities Moderator: Athanasios Alexiou Konstantinos Kalianiotis Giorgos Bamias (TBC) Melpomeni Peppa Lina Nikolopoulou Zoe Grammatoglou |
| 19:45 – 20:00 | 1st day - Closing remarks |
Session 3:
|
|
| 08:50 – 09:00 | Welcome - Opening remarks |
| 09:00 – 09:50 | Towards the implementation of a National Cancer Plan in Greece Moderator: Aimilios Negkis Adonis Georgiadis - Keynote speech for World Cancer Day Zenia Saridaki-Zorras Andreas Charalambous Giorgos Vassilopoulos Konstantinos Syrigos Elisavet Prodromou Michalis Himonas |
| 09:50 – 10:10 | Messages for the World Cancer Day Gerasimos Siasos (TBC) Cary Adams Fabrice Andre Eduardo Pisani Christos Tsagkaris |
| 10:10 – 10:30 | Keynote speech Antonia Vogt |
| 10:30 – 10:40 | ELLOK Ambassador Nikolaos Floros |
| 10:40 – 10:50 | Award - Message of Legends 2004 |
| 10:50 – 11:00 | Break |
| 11:00 – 12:00 | Towards an effective financing model Moderator: Vassiliki Angouridi Panos Kanavos Aris Angelis Pavlina Karasiotou Olimpios Papadimitriou Vassilis Pentafragkas Lambrina Barbetaki |
| 12:00 – 13:00 | Connecting the National & the European Perspective in Cancer Care Policies Moderator: Panagiota Karlatira George Stilios Georgios Georgantas (TBC) Sevi Voloudaki Ioannis Tsimaris Athina Linou Stelios Kympouropoulos |
| 13:00 – 14:00 | Greece: The Country Cancer Profile (O.E.C.D) Moderator: Kostas Athanasakis Marios Themistocleous Presentantion - Caroline Berchet Emmanuel Alexandrakis Konstantina Mponiou Ioannis Karaitianos Nikolaos Kostaras (TBC) |
| 14:00 – 15:00 | Lunch |
Session 4
|
|
| 15:00 – 15:45 | Mapping cancer patients' experiences Moderator:George Sakkas Kiriakos Souliotis Maria Gazouli Andreas Skolarikos Nikolaos Tsoukalas Nikolaos Kikilias Ioannis Koutsikos Ioanna Karavana |
| 15:45 – 16:30 | Unmet medical needs Moderator:Athanasios Vozikis Ioannis Kotsiopoulos Ioannis Boukovinas Eirini Throuvala Florentia Fostira Maria Tzima |
| 16:30 - 16:45 Break | |
| 16:45 – 17:45 | The contribution of clinical trials for the improvement of patients' lives Moderator: Euaggelia Koraki Lilian Vildiridi Eirini Katodritou Ioannis Xondrelis Despina Makridaki Mixalis Liontos |
| 17:45 – 18:15 | Validation of the European Oncology Quality of Life Toolkit Presentation Anthoula Lagiou Christina Adam |
| 18:15 – 19:45 | 40 years HeSMO: The significant work of HeSMO |
| 19:45 – 20:00 | 2nd day – Closing remarks |
Session 5:
|
|
| 09:00 – 09:10 | Opening remarks Keynote speech - Anastasios Gaitanis |
| 09:10 – 09:30 | Speech: A new digital era in health Ioannis Karagiannis |
| 09:30 – 10:30 | Digital transformation in cancer care: National Cancer Registry – Digitalization of Oncological Hospitals – Digital application for patients Moderator: George Kapetanakis Niki Tsouma Panagiota Mitrou Alexandros Bregiannis Kostis Kangelidis Konstantinos Chalkias Alexander Berler Κίμων Α. Φογκτ |
| 10:30 – 11:30 | European Health Data Space and Interoperability Moderator: Antonis Billis Asimina Boubaki Nikolaos Iosif George Megas Ioanna Michalopoulou Dimitris Katehakis |
| 11:30 – 12:00 | Break |
| 12:00 – 13:00 | ECHoS: Establishing Cancer Mission National Hubs Moderator: Sofia Xesfingi Jinane Ghattas Hugo Soares Ian Gauci – Borda George Kapetanakis |
| 13:00 – 14:00 | Lunch |
| 14:00 – 14:45 | Pharos, the Greek AI Factory: Focus on Health Kostas Athanasakis Stefanos Kollias Dimitris Gerogiannis |
| 14:45 – 15:30 | Creating innovative solutions in digital era Moderator: Theodoros Pasxalis Improving efficiency in radiation oncology Anestis Chatziioannou Digital Twins - Designing the future in oncology Georgios S. Stamatakos Biofeedback for stress management of cancer patients Euaggelia Daskalaki, Konstantinos Kalianiotis, Athanasios Alexiou |
| 15:30 – 16:00 | Innovation and Collaboration in Cancer Research: Living Labs and Lifelong Approaches Moderator: Katerina Nikitara Despina Mantziari Katerina Nikitara Antonis Billis |
| 16:00 – 16:15 | Break |
| 16:15 – 17:00 | Participating in European research programs Moderator: Leonidas Alexopoulos Georgios Dedousis Fofo Kaliva Anastasia Balasopoulou Vasiliki Gioka Nicola Di Flora Maria Theodoridou |
| 17:00 – 17:10 | Closing remarks |
Click the button below to register.
Breda Joao
WHO Athens Office for Quality of Care and Patient Safety and Special Adviser of the WHO Regional Director
Pisani Eduardo
CEO της All.Can International
Georgiadis Adonis
Minister of Health
Agapidaki Eirini
Deputy Minister of Health
Aris Angelis
Secretary General of Strategic Planning, Ministry of Health
Angouridi Vasiliki
Journalist
Agorastos Theodoros
Professor of Obstetrics and Gynecology, Aristotle University of Thessaloniki & President of the Board of Directors of the Hellenic HPV Society
Adam Christina
Head of the A' Pathological Oncology Department at the G.A.O.N.A. "Agios Savas" Hospital
Athanasakis Kostas
Assistant Professor of Health Economics and Health Technology Assessment, University of West Attica
Athanasiou Dimitrios
President of the Board of Directors of the Hellenic Union of Rare Diseases, Member of the Board of Directors of the Hellenic Patients Association, Member of the Patient and Consumer Working Party (PCWP) of the European Medicines Agency.
Alexandrakis Emmanuel
Adjunct Professor & Strategy and Internationalization Consultant, MBA International, Athens University of Economics and Business, Strategy Consultant, Economic Research Institute, WifOR Institute.
Alexiou Athanasios
Professor of Biomedical Informatics, Researcher at Funogen Research Institute, Chandigarh University
Alexopoulos Leonidas
Professor at the School of Mechanical Engineering, National Technical University of Athens, Director & Co-Founder of Protavio
Antonopoulos Christos
Director of the Oncology-Hematology Department, Board Member, AstraZeneca Greece & Cyprus
Arkadopoulos Nikos
Professor of Surgery, Medical School of National and Kapodistrian University of Athens (NKUA), Vice President of the Medical School of NKUA, Director of the 4th Surgical Clinic, Attikon University General Hospital.
Vassilopoulos Georgios
Professor of Pathology-Hematology at the Department of Medicine, University of Thessaly, Director of the Hematology Department at the University General Hospital of Larissa, President of the Hellenic Hematological Society (EOE).
Vassos Nikolaos
General Surgeon – Surgical Oncologist, Professor of Surgery, University of Heidelberg, Professor of Surgery and Surgical Oncology, European University Cyprus, Director of the Surgical Oncology Clinic and Head of the Sarcoma, Melanoma, and Rare Tumors Center, Athens Medical Center, Athens.
Vildiridi Lilian
Secretary General of Health Services
Vozikis Athanasios
Director of the "Health Economics & Management" Laboratory at the University of Piraeus, Former President of the Negotiation Committee of the National Organization for Healthcare Services Provision (E.O.P.Y.Y.), and Member of the National Public Health Council.
Voloudaki Sevi
Member of Parliament
Gazouli Maria
Professor of Biology-Genetics-Nanomedicine, Medical School of National and Kapodistrian University of Athens (NKUA), Member of the Board of Directors, National Council for Health (KESY)
Gaitanis Anastasios
General Secretary for Research and Innovation
Gerogiannis Dimitris
AI and Me, Founder & Tech Lead / AI Catalyst, Founder
Georgakopoulos Christos
Market Access Director of SfEE
Georgantas Georgios
Vice President of the Hellenic Parliament & President of the Special Standing Committee on Parliamentary Ethics
Gkioka Vassiliki
Head of the Independent Department of Quality Control, Research, and Continuing Education at “Agios Savvas” Hospital
Grammatoglou Zoi
President of the Cancer Patients Association K.E.F.I. Athens
Daskalaki Evangelia
Neurologist at the Neurological Therapy Center for Day Hospital Rehabilitation, Neurological Therapy Center Cologne (NTC), Cologne
Dedes Nikolaos
Secretary General of the Hellenic Patients' Association
Dimopoulos Meletios - Athanasios
Professor and Chair, Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens (NKUA), Alexandra Hospital.
Eleutheriadis Eleutherios
Vice President of the Hellenic Society of Pathological Anatomy (HSPA), CEO of "Historesearch S.A.
Eustathopoulos Sarantos
Director of the Metaxa Cancer Hospital in Piraeus
Themistocleous Marios
Deputy Minister of Health
Theodoridou Maria
Γραμματέας ΔΣ της ΕΛΛΟΚ, Πρόεδρος Συλλόγου Ευ Ζω με τον Καρκίνο.
Thiraios Eleutherios
General/Family Physician, Director of the National Health System (NHS) at the 2nd PEDY/Health Center of Vari
Throuvala Eirini
Nurse, Unit of Medical Oncology & Hematology of Gynecological Cancer, “Elena Venizelou” General Hospital, Treasurer of the Executive Board of the Hellenic National Union of Nurses, Member of the Executive Board of All.Can Greece
Iosif Nikolaos
President of H.H.I. (Human Health Intelligence organization), CEO of Brains I.C.S.
Kangelidis Kostis
CEO στη Gnomon Informatics SA
Kalianiotis Konstantinos
Special Education Teacher, Scientific Associate at the Intensive Care Unit, B' Pediatric Clinic of the University of Athens
Kaltsas Grigorios
Professor of Pathology – Endocrinology at the Medical School of the National and Kapodistrian University of Athens (NKUA)
Kaliva Fofo
Secretary General of Public Health, Ministry of Health.
Kanavos Panos
Ass. Director, LSE Health, Department of Social Policy, London School of Economics
Kani Chara
Pharmacist, Head of the Pharmaceutical Directorate, General Directorate of Organization and Planning of Health Services at National Organization for Healthcare Services in Greece
Kapetanakis George
President of Hellenic Cancer Federation
Karavana Ioanna
Board Member of ELLOK, President of the Cancer Patients Association of Larissa
Karagiannis Ioannis
President of IDIKA
Karathanos Charalambos
Pharmaceutical Policy Advisor to the Minister of Health – Member of the Drug Pricing Negotiation Committee of the Ministry of Health
Katehakis Dimitris
Head of the Center for Applications and Services - Health, FORTH-ICS & Director of the Hellenic Digital Health Cluster
Karasiotou Pavlina
General Secretary for Fiscal Policy
Karlatira Panagiota
Journalist
Karpodini Theano
CEO and President of the Board of the National Organization for Healthcare Services (E.O.P.Y.Y.)
Kattamis Antonis
Professor of Pediatric Hematology-Oncology, School of Medicine, National and Kapodistrian University of Athens (EKPA), Department of Pediatric Hematology-Oncology, 1st Pediatric Clinic EKPA, "Agia Sophia" Children's Hospital.
Katodritou Eirini
Hematologist – Director of the Hematology Department, A.N.TH. "Theageneio" Hospital
Kikilias Nikolaos
Προϊστάμενος Διεύθυνσης Διεθνών Ασφαλιστικών Σχέσεων ΕΟΠΥΥ
Kollias Stefanos
President of the Board of the National Network of Technology and Research Infrastructures (EDYTE)
Koraki Euaggelia
President of the Hellenic Association of CROs – HACRO, President & CEO of CORONIS Research
Kotsiopoulos Ioannis
CEO of Pharma Innovation Forum (PIF)
Koukougianni Menia
Co-Founder of Karkinaki
Koukouraki Sofia
Professor of Nuclear Medicine at the Medical School of the University of Crete, General Secretary of the Hellenic Society of Nuclear Medicine and Molecular Imaging
Kountoura Elena
Member of the European Parliament with SYRIZA, President of Europa Donna Hellas
Kourea Eleni
Professor of Pathological Anatomy, Department of Medicine, University of Patras, President of the Hellenic Society of Pathological Anatomy (H.S.P.A.)
Koutsikos Ioannis
Director of the Department of Nuclear Medicine at 401 General Military Hospital of Athens & Errikos Ntinan Hospital Center, President of the Hellenic Society of Nuclear Medicine and Molecular Imaging
Kympouropoulos Stelios
Psychiatrist – Sexologist, former Member of the European Parliament
Lagiou Anthoula
Head of the Home Care Department and the Oikothen Program at GNA Agios Savvas.
Linou Athina
Professor of Epidemiology, Member of Parliament
Liontos Michalis
Ass. Professor of Therapeutics – Oncology, Medical School of National and Kapodistrian University of Athens (NKUA), Board Member of the Hellenic Society of Medical Oncology (HeSMO).
Makridaki Despina
President of the Hellenic Association of Pharmacists of Healthcare Institutions (PEFNI)
Mantziari Despina
Researcher, Laboratory of Medical Physics & Digital Innovation, Aristotle University of Thessaloniki (A.U.TH.)
Megas George
Innovation Ecosystems & EU afairs, Institute of Communication & Computer Systems (ICCS)
Mitrou Panagiota
Pathologist – Diabetologist, Head of the Independent Department of Therapeutic Protocols and Patient Registries, Ministry of Health
Michalopoulou Ioanna
Lawyer specializing in Health, Pharmaceuticals, and Medical Technology.
Mixalopoulou Paraskevi
Vice President of Hellenic Cancer Federation, President of Alma Zois
Bacopoulou Flora
President of the Committee for the Evaluation & Reimbursement of Medicines, Ministry of Health, Professor of Pediatrics – Adolescent Medicine – Clinical Pharmacology, Medical School of National and Kapodistrian University of Athens (NKUA), “Agia Sophia” Children's Hospital
Balaoura Olga
Director of the 1st Health Region of Attica (1st YPE Attica)
Balasopoulou Anastasia
Head of the Directorate of Planning and Development of Public Health and Primary Care Policies.
Bamias Aristotelis
Professor of Therapeutic Pathology-Oncology, School of Medicine, National and Kapodistrian University of Athens (EKPA), 2nd Preclinical Pathology Clinic, Attikon University Hospital, Vice President of the Board of Directors of the Hellenic Research Group of Urogenital Cancer.
Bamias Georgios
Professor of Gastroenterology at the University of Athens, President of the Hellenic Group for the Study of Inflammatory Bowel Diseases
Bamidis Panagiotis
Professor of Medical Physics and Informatics in Medical Education at the Laboratory of Medical Physics, School of Medicine, Aristotle University of Thessaloniki (A.U.Th.).
Barbetaki Labrina
President of the PhARMA Innovation Forum (PIF), President and Managing Director of AbbVie Greece, Cyprus, and Malta.
Berler Alexander
Director of Business Strategy & Development at IHE Catalyst AISBL, R&D Lead at Gnomon Informatics SA.
Billis Antonis
Μεταδιδακτορικος ερευνητής στο εργαστήριο ιατρικής φυσικής και ψηφιακής Καινοτομίας, ΑΠΘ
Boniou Konstantina
Radiation Oncologist, Director of the Radiation Oncology Department, A.N.TH. "Theageneio" Hospital, Vice President of the Hellenic Society of Radiation Oncology (HESRO)
Boukovinas Ioannis
Medical Oncologist, Director of the Oncology Unit at Bioclinic Thessaloniki.
Boubaki Asimina
Head of the Department of Electronic Health Services – Ministry of Health.
Boutis Anastasios
Oncologist at the Thessaloniki Cancer Hospital "Theageneio"
Bregiannis Alexandros
CEO, Nova ICT
Negkis Aimilios
Journalist
Nikitara Katerina
Head of the European Programs of ELLOK
Nikolaou Michalis
Pathologist Oncologist, Senior Consultant, A' Pathological Oncology Clinic, G.A.O.N.A. "Agios Savvas", Vice President of HeSMO
Nikolopoulou Lina
CEO, Mindview
Ξεσφίγγη Σοφία
Σύμβουλος έρευνας & καινοτομίας στο Εθνικό Κέντρο Τεκμηρίωσης & Ηλεκτρονικού Περιεχομένου – Project Manager του έργου ECHoS & Εθνικό Σημείο Επαφής στον Ορίζοντα Ευρώπη για το Cluster Health
Papageorgiou Dimitrios
Associate Professor of Pathological Nursing at the University of the Peloponnese, Head of ODC at Euroclinic of Athens, President of the Oncology Nursing Sector of the Hellenic Nurses Association (ESNE-TNO)
Papadimitriou Mani Anna
Deputy Minister of Development
Papadimitriou Olymbios
President of the Hellenic Federation of Pharmaceutical Enterprises (SFEE) & General Director of Novo Nordisk Greece
Papadopoulou Maxaira Aikaterini
MD at Groningen University, Netherlands
Papandreou Nikos
Member of the European Parliament
Pasxalis Theodoros
Head of the Contracts Department of the National Organization for Healthcare Services (E.O.P.Y.Y.)
Pentafragkas Vassilis
Executive Advisor of PEF, Director of Public and Regulatory Affairs at ELPEN.
Peppa Melpomeni
Professor of Endocrinology, NKUA
Printza Athanasia
Professor of ENT – Phoniatrics, Department of Medicine, Aristotle University of Thessaloniki (AUTH), EC The Association of Medical Schools in Europe, European Academy of Sciences and Arts.
Prodromou Elisavet
Chief Manager of BMS, General Secretary of Pharma Innovation Forum (PIF)
Sakkas George
Journalist
Samolada Maria
Journalist
Saridaki Zoras Zenia
President of HeSMO, Medical Oncologist, Director of the A' Oncology Clinic at Metropolitan Hospital & Scientific Director of the Oncology Department at "Asklepios DIAGNOSIS"
Siamos Gerasimos
Rector of the National and Kapodistrian University of Athens, Professor of Cardiology
Skolarikos Andreas
Professor of Urology – Director of the B' Urological Clinic at the National and Kapodistrian University of Athens (NKUA), "Sismanogleio" Hospital, President of the Hellenic Urological Society
Souliotis Kiriakos
Professor of Health Policy at the School of Social and Political Sciences, University of the Peloponnese
Stamatakos S. Georgios
Research Professor
Director of the Research Group for In Silico Oncology and In Silico Medicine
National Technical University of Athens (ICCS, ECE)
Stefanaki Angeliki
Treasurer of ELLOK, President of Alma Zois N. Achaias
Stilios Georgios
President of the Standing Committee on Educational Affairs of the Hellenic Parliament
Syrigos Konstantinos
Professor of Oncology Pathology at the Medical School of National and Kapodistrian University of Athens (NKUA), Head of the Oncology Unit and the Oncology Laboratory, 3rd Department of Pathology, University of Athens, "Sotiria" General Hospital
Tzima Maria
Board Member of ELLOK, Secretary of the Association of Cancer Patients, Friends & Families of Northwestern Greece "WE ARE TOGETHER.
Tolia Maria
Associate Professor of Radiotherapy, School of Medicine, University of Crete, Head of the Radiotherapy Department at PAGNI
Topali Despina
General Secretary of the Board of Directors of the Panhellenic Association of Health Visitors
Tsimaris Ioannis
Member of the Greek Parliament
Tsiodras Dimitrios
Member of the European Parliament
Tsoukalas Nikolaos
MD, MSc, PhD, Pathologist - Oncologist, MSc in Bioinformatics, Director, Oncology Department, 417 NIMTS, Scientific Collaborator, "Errikos Ntinan" Hospital, Athens
Tsouma Niki
CEO of IDIKA
Yfantopoulos John
Professor of Health Economics
University of Athens
School of Economics and Political Science
Chalkias Konstantinos
Executive Member of the Board of Directors at the Center for Documentation and Costing of Hospital Services (KE.TE.K.N.Y.).
Floros Nikolaos
Artist - Ambassador of ELLOK
Vogt Antonia
PhD candidate in Surgery at the University of Cambridge, UK
Φογκτ Κίμωνας
CEO & Co-Founder Sporo Health, MS Harvard
Fostira Florentia
Clinical Laboratory Geneticist
Charalambous Andreas
Immediate past president of E.C.O. (European Cancer Organisation), Professor in Oncology and Palliative Nursing Care at the Cyprus University of Technology and Adjunct Professor (Docent) at the University of Turku, Finland
Chatziioannou Anestis
Director of the Radiotherapy Division, PAPAPOSTOLOU HEALTHCARE TECHNOLOGIES
Chatzioannou Sofia
Professor of Nuclear Medicine, National and Kapodistrian University of Athens (NKUA)
Chondrelis Ioannis
Director of the Medical Department at Pharmaserv-Lilly, Coordinator of the Clinical Trials Group at the Hellenic Association of Pharmaceutical Companies (SfEE)
Psaltopoulou Theodora
Professor of Therapeutics, Epidemiology, and Preventive Medicine, School of Medicine, National and Kapodistrian University of Athens
Psirri Amanda
Professor at the Medical School of NKUA, Director of the 2nd Pediatric Clinic, Attikon University Hospital
Adams Cary
CEO at the Union for International Cancer Control
Berchet Caroline
Health economist at the OECD Health Division
Soares Hugo
Co-coordinator of ECHoS project, Science Manager, AICIB – Agência de Investigação Clínica e Inovação Biomédica
Tamamyan Gevorg
Editor-in-Chief, OncoDaily | Chair & Professor, Dept. of Ped. Oncology & Hematology, YSMU | CEO, Immune Oncology Research Institute | President, SIOP Asia | President, POEM Group
Gauci – Borda Ian
National Contact Point and Programme Committee Member for Health, the Cancer Mission, Widening, European Research Area & Research Infrastructures
Ghattas Jinane
Project Manager at Sciensano, Teaching assistant at the Institute of Health and Society (IRSS) and the Faculty of Public Health at the Université catholique de Louvain
AUSPICES
ELLOK's Conference is under the Auspices of the Ministry of Health.
PLATINUM SPONSORS
The AstraZeneca είναι μια παγκόσμια βιοφαρμακευτική εταιρεία, που εστιάζει στην ανακάλυψη, ανάπτυξη και εμπορία συνταγογραφούμενων φαρμάκων στην Ογκολογία, τις Σπάνιες Παθήσεις και τη Βιοφαρμακευτική, συμπεριλαμβανομένων των Καρδιαγγειακών, Νεφρικών και Μεταβολικών παθήσεων, Αναπνευστικών παθήσεων και στην Ανοσολογία. Με έδρα το Κέιμπριτζ του Ηνωμένου Βασιλείου, η AstraZeneca δραστηριοποιείται σε περισσότερες από 100 χώρες και τα καινοτόμα φάρμακά της χρησιμοποιούνται από εκατομμύρια ασθενείς σε όλο τον κόσμο. Περισσότερες πληροφορίες για την AstraZeneca μπορείτε να βρείτε .
Η Βristol-Myers Squibb είναι μία διαφοροποιημένη εταιρία καθοδηγούμενη από τη στρατηγική ανάπτυξης βιοφαρμακευτικών προϊόντων, βάσει της οποίας αξιοποιεί τις δυνατότητες και τους πόρους μίας μεγάλης φαρμακευτικής εταιρίας σε συνδυασμό με το επιχειρηματικό πνεύμα και την ευελιξία μίας εταιρείας βιοτεχνολογίας. Εργαζόμαστε καθημερινά για να παρέχουμε καινοτόμα φάρμακα στους ασθενείς που αντιμετωπίζουν σοβαρές και απειλητικές για τη ζωή ασθένειες σε τομείς όπως η ογκολογία, τα καρδιαγγειακά νοσήματα, η ανοσολογία και η ίνωση. Μέσω του τομέα Έρευνας & Ανάπτυξης που διαθέτουμε, έχουμε δημιουργήσει μία βιώσιμη γραμμή ανάπτυξης πιθανών θεραπειών και αναπτύσσουμε συνεργασίες ώστε να διευρύνουμε και να επιταχύνουμε την πρόσβαση στην καινοτομία.
Για περισσότερες πληροφορίες, επισκεφτείτε την ιστοσελίδα μας, στη διεύθυνση: www.bms-greece.gr
Στην MSD, γνωστή ως Merck & Co., Inc Rahway, NJ, ΗΠΑ στις Ηνωμένες Πολιτείες και στον Καναδά, ενώνουμε τις δυνάμεις μας για την επίτευξη του κοινού μας σκοπού: Χρησιμοποιούμε τη δύναμη των επιστημών αιχμής, για να βελτιώνουμε τις ζωές των ανθρώπων σε όλο τον κόσμο. Για περισσότερα από 130 χρόνια, φέρνουμε την ελπίδα στους ανθρώπους ανακαλύπτοντας και αναπτύσσοντας σημαντικές θεραπείες και εμβόλια. Φιλοδοξούμε να είμαστε μια βιοφαρμακευτική εταιρεία με εξέχουσα θέση παγκοσμίως, εστιάζοντας στην εντατική έρευνα, για να συμβάλλουμε στην παροχή καινοτόμων θεραπευτικών λύσεων που προάγουν την πρόληψη και τη θεραπεία ασθενειών σε ανθρώπους και ζώα. Καλλιεργούμε ένα εργασιακό περιβάλλον διαφορετικότητας και συμπερίληψης και λειτουργούμε υπεύθυνα για να δημιουργήσουμε ένα ασφαλές, βιώσιμο και υγιές μέλλον για όλους τους ανθρώπους και τις κοινότητες.
H MSD in Greece
Από το 2010, η MSD κάνει πράξη το όραμά της στην Ελλάδα: Να βελτιώνει τις ζωές των ανθρώπων προσφέροντας θεραπείες στους τομείς της ογκολογίας, των εμβολίων, των λοιμωδών νοσημάτων, του διαβήτη και της καρδιολογίας που καλύπτουν ανάγκες σε όλη τη διάρκεια της ζωής του ανθρώπου. Ταυτόχρονα, διασφαλίζει ότι η δραστηριότητά της έχει θετικό αντίκτυπο στην κοινωνία, υλοποιώντας δράσεις που συμβάλλουν σε μια βιώσιμη Ελλάδα και αναπτύσσοντας συνεργασίες που επενδύουν στην παραγωγικότητα και την ανάπτυξη της χώρας.
Σήμερα, η MSD διαθέτει ένα εργατικό δυναμικό με περισσότερους από 250 αφοσιωμένους υπαλλήλους, παρέχοντας ένα εξαιρετικό περιβάλλον εργασίας που είναι πιστοποιημένο ως “Great Place to Work”.
Επιπλέον, το 2024, η MSD τιμήθηκε για άλλη μια φορά για τη δέσμευσή της στη βιωσιμότητα, επιβεβαιώνοντας τη θέση της ανάμεσα στις «πιο βιώσιμες εταιρείες» στην Ελλάδα. Περισσότερες πληροφορίες είναι διαθέσιμες στο νέο Impact Report 2023/2024 which is on our website μας https://www.msd.gr και στα κανάλια μας στα Social Media, LinkedIn, Facebook, Twitter και YouTube.
PAPAPOSTOLOU: 111 ΧΡΟΝΙΑ ΣΥΝΕΧΟΥΣ ΠΑΡΟΥΣΙΑΣ ΣΤΟΝ ΧΩΡΟ ΤΗΣ ΥΓΕΙΑΣ
The PAPAPOSTOLOU Healthcare Technologies διανύει το 111ο έτος λειτουργίας και προσφοράς στον χώρο της Υγείας. Το 1914 πραγματοποιείται η έναρξη της ομώνυμης επιχείρησης στη Θεσσαλονίκη από τον Αθανάσιο Παπαποστόλου. Ο ιδρυτής και οι συνεργάτες του παρείχαν στον συνάνθρωπο όλα τα τότε γνωστά εφόδια για την αντιμετώπιση προβλημάτων υγείας και παράλληλα εξόπλιζαν ιατρεία, νοσοκομεία και κλινικές, με όσα όργανα πρόσφερε η τότε τεχνολογία.
Η λήξη του B’ Παγκοσμίου Πολέμου σηματοδοτεί μια νέα εποχή στον χώρο της υγείας καθώς μεγάλο μέρος από την τεχνολογία που αναπτύχθηκε από την πολεμική βιομηχανία μεταφέρθηκε μετά το πέρας του για την κατασκευή μηχανημάτων για την πρόληψη, διάγνωση και αποκατάσταση της ανθρώπινης υγείας. Είναι η εποχή που η ΠΑΠΑΠΟΣΤΟΛΟΥ επεκτείνεται σε όλη την Ελλάδα καθώς υιοθετεί την τεχνολογία και πρωτοπορεί με την εισαγωγή καινοτόμων ιατρικών μηχανημάτων στην Ελληνική αγορά.
Ενδεικτικά αναφέρονται τα ακόλουθα
-
εγκατέστησε το πρώτο μηχάνημα Υπερήχων Ecoline10 στο Νοσοκομείο “O ΕΥΑΓΓΕΛΙΣΜΟΣ”
-
εγκατέστησε την πρώτη Ψηφιακή γ-κάμερα Pegasus στην Ευρώπη, στο “ΘΕΑΓΕΝΕΙΟ ΑΝΤΙΚΑΡΚΙΝΙΚΟ ΝΟΣΟΚΟΜΕΙΟ ΘΕΣΣΑΛΟΝΙΚΗΣ”
-
υποστήριξε τον 1ο Γραμμικό επιταχυντή Varian που εγκαταστάθηκε στην Ελλάδα κατά το έτος 2000, με uptime 99% διατηρώντας το για πάνω από 20 συνεχόμενα έτη μέχρι την αντικατάστασή του
Αναγνωρίζοντας την ανάγκη παροχής άριστης τεχνικής υποστήριξης των μηχανημάτων για διασφάλιση συνεχούς λειτουργίας αυτών, η ΠΑΠΑΠΟΣΤΟΛΟΥ στελέχωσε και διατηρεί ένα υψηλών προδιαγραφών πολυπληθές Τμήμα Τεχνικής Υποστήριξης, επιτυγχάνοντας 99% uptime.
Όραμά μας είναι να αποτελέσουμε την πρώτη επιλογή στη συνείδηση της Ιατρικής κοινότητας ως ο πλέον αξιόπιστος πάροχος ολοκληρωμένων ιατροτεχνολογικών λύσεων. Η πορεία προς το όραμα μας ορίζεται από τις αξίες που πρεσβεύει η εταιρική κουλτούρα μας: κοινωνική υπευθυνότητα, επιχειρηματική ηθική, ανθρώπινο δυναμικό, εστίαση στον πελάτη, διασφάλιση άριστης ποιότητας, καινοτομία και αξιοπιστία.
GOLD SPONSORS
SPONSORS
OFFICIAL MEDIA PARTNER
MEDIA SPONSORS
AUDIO VISUAL SPONSOR
1st Day
2nd Day
3rd Day
